Tert-butyl 5-[(4-nitrophenyl)-piperidin-3-ylarsanyl]indazole-1-carboxylate
C23H27AsN4O4 — CID 87898543
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl 5-[(4-nitrophenyl)-piperidin-3-ylarsanyl]indazole-1-carboxylate
Tert-butyl 5-[(4-nitrophenyl)-piperidin-3-ylarsanyl]indazole-1-carboxylate (PubChem CID 87898543) has the molecular formula C23H27AsN4O4 and a molecular weight of 498.42 g/mol. Its IUPAC name is tert-butyl 5-[(4-nitrophenyl)-piperidin-3-ylarsanyl]indazole-1-carboxylate.
Molecular Properties
| Compound Name | Tert-butyl 5-[(4-nitrophenyl)-piperidin-3-ylarsanyl]indazole-1-carboxylate |
|---|---|
| PubChem CID | 87898543 |
| Molecular Formula | C23H27AsN4O4 |
| Molecular Weight | 498.42 g/mol |
| Exact Mass | 498.12 |
| IUPAC Name | tert-butyl 5-[(4-nitrophenyl)-piperidin-3-ylarsanyl]indazole-1-carboxylate |
| SMILES | CC(C)(C)OC(=O)n1ncc2cc([As](c3ccc([N+](=O)[O-])cc3)C3CCCNC3)ccc21 |
| InChI | InChI=1S/C23H27AsN4O4/c1-23(2,3)32-22(29)27-21-11-8-18(13-16(21)14-26-27)24(19-5-4-12-25-15-19)17-6-9-20(10-7-17)28(30)31/h6-11,13-14,19,25H,4-5,12,15H2,1-3H3 |
| InChIKey | ORGFRZIEOIEXCJ-UHFFFAOYSA-N |
| XLogP | 3.09 |
| TPSA | 99.29 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 498.42 |
| LogP ≤ 5 | 3.09 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 87898543 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.